ContentsSynopsisCodesDifferential Diagnosis & PitfallsBest TestsDrug Reaction DataReferences
Hemolytic anemia
Print
Other Resources UpToDate PubMed

Hemolytic anemia

Print Images (1)
Other Resources UpToDate PubMed

Synopsis

Hemolytic anemia is premature destruction of red blood cells before their average lifespan of 120 days. This results in anemia, since bone marrow typically cannot supply enough new red blood cells to maintain regular function. Occasionally, bone marrow is able to replace red blood cells on a shortened life span schedule. This is called compensated hemolytic anemia. Etiology includes genetic defects, infections, and certain drugs or toxins. Closely associated with glucose-6-phosphate dehydrogenase deficiency. Signs and symptoms include irritability, fatigue, headache, pallor, and hypotension. More advanced cases may present with jaundice and splenomegaly. Mild cases may be asymptomatic, and the disease can progress slowly.

Treatments include blood transfusions, immunosuppressant drugs, or replacement therapy. Splenectomy may be necessary.

Codes

ICD10CM:
D59.9 – Acquired hemolytic anemia, unspecified

SNOMEDCT:
61261009 – Hemolytic Anemia

Differential Diagnosis & Pitfalls

Best Tests

Subscription Required

Drug Reaction Data

Below is a list of drugs with literature evidence indicating an adverse association with this diagnosis. The list is continually updated through ongoing research and new medication approvals. Click on Citations to sort by number of citations or click on Medication to sort the medications alphabetically.

Subscription Required

References

Subscription Required

Last Updated: 12/29/2017
Copyright © 2019 VisualDx®. All rights reserved.
Hemolytic anemia
Print 1 Images
Hemolytic anemia : Fatigue, Headache, Jaundice, Dyspnea, RBC decreased
Copyright © 2019 VisualDx®. All rights reserved.